Bronchial Thermoplasty in Severe Persistent Asthma: Critical Observations in Pulmonary Medicine, Ep. 4
In this episode, Dr Rizzo interviews Geoffrey Chupp, MD, on his team’s research titled "Bronchial Thermoplasty in Patients with Severe Asthma at 5 years: Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study." Dr Chupp speaks about the efficacy, safety results, challenges, and controversies of the therapy.

 Biologics as Treatment Alternative for Hypereosinophilic Syndrome
Although immunomodulators are often used to treat HES, a group of rare conditions characterized by a persistently higher than normal level of eosinophils and evidence of organ damage, biologics may be a better-tolerated alternative.

 Hot Topics at ATS 2022
In this podcast, Andrew Halayko, PhD, ATSF, summarizes hot topics to be discussed at the American Thoracic Society (ATS) 2022 International Conference, including how COVID-19 has influenced the program agenda and highly anticipated keynote, clinical, and research sessions.

 Allen J. Dozor, MD, on Developing a High-Risk Asthma Program
Allen J. Dozor, MD, from New York Medical College, answers our questions about his work in developing high-risk asthma programs, and explains how other practitioners can implement similar programs.

Microbiome and Allergic Disease Development
In this episode, Kirsten Kloepfer, MD, speaks about her team’s review titled “The Role of Microbiome in Allergic Disease Development,” including the link between microbiota and immune development and ways to prevent allergic disease development in early life. 

Sandhya Khurana, MD, on Best Practices for Managing Severe Asthma
Sandhya Khurana, MD, from the University of Rochester, answers our questions about evidence-based best practices when addressing the special needs of patients with severe asthma.